Oscar Health, Inc. $OSCR Shares Sold by SG Americas Securities LLC

SG Americas Securities LLC reduced its holdings in shares of Oscar Health, Inc. (NYSE:OSCR) by 13.1% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 800,984 shares of the company’s stock after selling 120,304 shares during the period. SG Americas Securities LLC’s holdings in Oscar Health were worth $9,187,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Hsbc Holdings PLC bought a new position in Oscar Health during the 4th quarter valued at $486,000. Rockefeller Capital Management L.P. grew its holdings in Oscar Health by 75.8% during the 4th quarter. Rockefeller Capital Management L.P. now owns 10,564 shares of the company’s stock worth $152,000 after acquiring an additional 4,555 shares in the last quarter. Gunpowder Capital Management LLC dba Oliver Wealth Management bought a new stake in shares of Oscar Health in the 4th quarter worth about $84,000. Virtu Financial LLC increased its position in shares of Oscar Health by 99.4% in the 4th quarter. Virtu Financial LLC now owns 127,647 shares of the company’s stock worth $1,834,000 after purchasing an additional 63,623 shares during the last quarter. Finally, T. Rowe Price Investment Management Inc. raised its stake in shares of Oscar Health by 11.0% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 9,217,816 shares of the company’s stock valued at $132,461,000 after purchasing an additional 910,320 shares in the last quarter. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities analysts have recently commented on OSCR shares. Barclays raised shares of Oscar Health from an “equal weight” rating to an “overweight” rating and increased their price target for the stock from $30.00 to $35.00 in a research report on Wednesday, June 10th. Wells Fargo & Company set a $20.00 price objective on Oscar Health and gave the company an “equal weight” rating in a report on Thursday, June 4th. Wolfe Research began coverage on Oscar Health in a research note on Tuesday, May 5th. They set a “peer perform” rating on the stock. Robert W. Baird increased their target price on Oscar Health from $15.00 to $19.00 and gave the stock a “neutral” rating in a report on Thursday, May 7th. Finally, Jefferies Financial Group upgraded Oscar Health from an “underperform” rating to a “hold” rating and lifted their target price for the stock from $10.00 to $16.00 in a research report on Monday, April 20th. Three analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $20.78.

Oscar Health Trading Up 3.8%

Oscar Health stock opened at $29.77 on Friday. The firm’s 50-day moving average is $23.03 and its 200-day moving average is $17.36. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.11 and a current ratio of 1.11. Oscar Health, Inc. has a 1 year low of $10.69 and a 1 year high of $30.38. The company has a market cap of $8.97 billion, a P/E ratio of -50.45, a PEG ratio of 2.08 and a beta of 2.37.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $2.07 earnings per share for the quarter, beating analysts’ consensus estimates of $1.11 by $0.96. The business had revenue of $4.65 billion during the quarter, compared to the consensus estimate of $4.90 billion. Oscar Health had a negative net margin of 0.30% and a negative return on equity of 3.26%. The company’s revenue for the quarter was up 52.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.92 EPS. On average, equities analysts expect that Oscar Health, Inc. will post 0.47 earnings per share for the current year.

Insider Transactions at Oscar Health

In other Oscar Health news, insider Adam Mcananey sold 9,859 shares of Oscar Health stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total value of $216,306.46. Following the completion of the transaction, the insider directly owned 218,096 shares in the company, valued at $4,785,026.24. The trade was a 4.32% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Janet Liang sold 12,475 shares of the company’s stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $21.94, for a total value of $273,701.50. Following the transaction, the insider directly owned 259,057 shares of the company’s stock, valued at $5,683,710.58. This trade represents a 4.59% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 1,217,160 shares of company stock valued at $34,471,090 over the last ninety days. Insiders own 24.39% of the company’s stock.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.